Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Lopez Perez

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Genes|May 27, 2026
Current and Emerging Therapeutic Strategies for the Treatment of Duchenne Muscular DystrophyMiguel A Lopez Perez, Noah L Weisleder
Biomolecules|March 28, 2025
Enhancing Membrane Repair Using Recombinant MG53/TRIM72 (rhMG53) Reduces Neurotoxicity in Alzheimer's Disease ModelsHannah R Bulgart, Miguel A Lopez Perez, Noah Weisleder
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
In Vivo Electroporation of Plasmid DNA into the Skeletal Muscle of Dystrophic Mouse ModelsMiguel A Lopez Perez, Gianni N Giarrano, Noah L Weisleder
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHannah R Bulgart, Miguel A Lopez Perez, Gianni N Giarrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2024
Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expressionHannah R Bulgart, Miguel A Lopez Perez, Alexis Tucker, et al.
The Journal of Clinical Investigation|July 21, 2020
Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathyKevin E McElhanon, Nicholas Young, Jeffrey Hampton, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Genes|May 27, 2026
Current and Emerging Therapeutic Strategies for the Treatment of Duchenne Muscular DystrophyMiguel A Lopez Perez, Noah L Weisleder
Biomolecules|March 28, 2025
Enhancing Membrane Repair Using Recombinant MG53/TRIM72 (rhMG53) Reduces Neurotoxicity in Alzheimer's Disease ModelsHannah R Bulgart, Miguel A Lopez Perez, Noah Weisleder
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
In Vivo Electroporation of Plasmid DNA into the Skeletal Muscle of Dystrophic Mouse ModelsMiguel A Lopez Perez, Gianni N Giarrano, Noah L Weisleder
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHannah R Bulgart, Miguel A Lopez Perez, Gianni N Giarrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2024
Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expressionHannah R Bulgart, Miguel A Lopez Perez, Alexis Tucker, et al.
The Journal of Clinical Investigation|July 21, 2020
Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathyKevin E McElhanon, Nicholas Young, Jeffrey Hampton, et al.
Pageof 1